In the wake of US Supreme Court's win-win verdict in Association for Molecular Pathology vs Myriad Genetics case, Frost ...
Singapore: Denmark-based Lundbeck and Japanese company Otsuka Pharmaceutical have signed a license and development agree...
Singapore: Takeda Pharmaceutical has recieved Food and Drug Administration (FDA) approval for a new biologic therapy, En...
Singapore: The PGA Tour and subsidiary of Tokyo-based Astellas Pharma launched its first 'Astellas Presents Executive Wo...
Singapore: US-based ArQule and Japanese Daiichi Sankyo have completed the recruitment of patients for their randomized, ...
Singapore:Â Certara, leading provider of software and scientific consulting services to improve productivity and decis...
Singapore:Â Chugai Pharmaceutical and Debiopharm Group entered into a licensing agreement regarding FF284 (called Debi...
Singapore:Â ASKLEP, a leading Tokyo-based provider of clinical research services, has joined the Medidata Solutions Pa...
Singapore: Bayer has received Japan's approval for Stivarga indicated for the treatment of patients suffering from gastr...
Singapore: Noven Pharmaceuticals, a wholly-owned subsidiary of Japanese firm Hisamitsu Pharmaceutical, has submitted a n...
Singapore:Â Theravance and Alfa Wassermann entered into an exclusive development and commercialization agreement in ce...
Singapore: Japan's Meiji Seika Pharma is set to acquire Bangalore-based generic drug maker Medreich for $290 million. Th...
Singapore: Even as a new strain of stomach flu is infecting many across the world, scientists in Japan seem to have made...
Singapore: Eisai announced that the US Food and Drug Administration (FDA) has approved ACIPHEX Sprinkle Delayed-Re...
Singapore: Takeda Pharmaceutical has established the Global Medical Affairs Japan Department at Takeda Development Cente...
Singapore:Â Zeria Pharmaceutical and Astellas Pharma announced that, Zeria has obtained the marketing approval of Acof...
International pharmaceutical R&D and manufacturing conference and expo, the 25th Interphex Japan, concluded on a suc...
Singapore: Daiichi Sankyo has launched TaNeDS (Take a New challenge for Drug diScovery) collaborative drug discovery pro...
Singapore: The Shimadzu Global Pharma Summit 2012 held in Singapore sent out an unaninmous message that it is high time ...
Singapore: Scotland's health technology assessment body, Scottish Medicines Consortium (SMC), has approved Eisai's AMPA ...
Singapore: Japanese drugmaker Daiichi Sankyo, which currently holds a majority stake in Ranbaxy, had earlier highlighted...
Singapore: Japan-based global analytics technology provider, Shimadzu, has launched i-Series of new industry standard HP...
Singapore: Japanese company Daiichi Sankyo has received positive results for a double-blind randomized phase III trial c...
Singapore: UCL (University College London) and Japan based Takeda Pharmaceutical have formed a new research collaboratio...
Singapore: Canadian company Opsens signed its first major agreement granting distribution and other rights for its OptoW...
